| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
28,030,000 |
| Market
Cap: |
584.15(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$18.03 - $32.87 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 1180 |
| Guru Rank Value : 0 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile AdvanSix produces and sells caprolactam as a commodity product and produces and sells its Nylon 6 resin as both a commoditized and other resin product. Co.'s four main product lines are as follow: Nylon, which sells its Nylon 6 resin globally, primarily under the Aegis® brand name; Caprolactam, which is the key monomer used in the production of Nylon 6 resin; Chemical Intermediates, which manufactures, markets and sells a number of other chemical products that are derived from the chemical processes within its integrated supply chain; and Ammonium Sulfate Fertilizer, which markets and sells ammonium sulfate primarily to North American and South American distributors.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
5,030 |
5,030 |
| Total Buy Value |
$0 |
$0 |
$149,089 |
$149,089 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
1 |
1 |
| Total Shares Sold |
1,713 |
9,521 |
44,395 |
99,669 |
| Total Sell Value |
$37,817 |
$209,359 |
$1,263,701 |
$2,811,707 |
| Total People Sold |
1 |
1 |
3 |
3 |
| Total Sell Transactions |
3 |
6 |
18 |
38 |
| End Date |
2025-06-19 |
2025-03-18 |
2024-09-17 |
2023-09-18 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Kintiroglou Achilles B. |
SVP, General Counsel |
• – – |
2025-09-02 |
4 |
AS |
$21.20 |
$12,105 |
D/D |
(571) |
30,842 |
|
2% |
|
| Kintiroglou Achilles B. |
SVP, General Counsel |
• – – |
2025-08-01 |
4 |
AS |
$20.18 |
$11,523 |
D/D |
(571) |
31,413 |
|
12% |
|
| Gramm Christopher |
VP and Interim CFOOfficer |
• – – |
2025-07-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
54,570 |
|
-13% |
|
| Kintiroglou Achilles B. |
SVP, General Counsel |
• – – |
2025-07-02 |
4 |
AS |
$24.85 |
$14,189 |
D/D |
(571) |
31,984 |
|
-14% |
|
| Williams Patrick |
Director |
– • – |
2025-06-30 |
4 |
A |
$23.75 |
$13,110 |
D/D |
552 |
34,193 |
|
- |
|
| Newman Donald P |
Director |
– • – |
2025-06-30 |
4 |
A |
$23.75 |
$23,204 |
D/D |
977 |
12,026 |
|
- |
|
| Williams Patrick |
Director |
– • – |
2025-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
5,020 |
33,641 |
|
- |
|
| Newman Donald P |
Director |
– • – |
2025-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
5,020 |
11,049 |
|
- |
|
| Sansone Daniel F |
Director |
– • – |
2025-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
5,020 |
36,288 |
|
- |
|
| Karran Todd D. |
Director |
– • – |
2025-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
5,020 |
85,739 |
|
- |
|
| Lovett Gena C |
Director |
– • – |
2025-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
5,020 |
15,162 |
|
- |
|
| Spurlin Sharon |
Director |
– • – |
2025-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
5,020 |
74,746 |
|
- |
|
| Kintiroglou Achilles B. |
SVP, General Counsel |
• – – |
2025-06-02 |
4 |
AS |
$23.65 |
$13,504 |
D/D |
(571) |
32,555 |
|
-9% |
|
| Kintiroglou Achilles B. |
SVP, General Counsel |
• – – |
2025-05-01 |
4 |
AS |
$21.34 |
$69,078 |
D/D |
(3,237) |
33,126 |
|
-3% |
|
| Kintiroglou Achilles B. |
SVP, General Counsel |
• – – |
2025-04-01 |
4 |
AS |
$22.24 |
$88,960 |
D/D |
(4,000) |
36,363 |
|
-18% |
|
| Newman Donald P |
Director |
– • – |
2025-03-31 |
4 |
A |
$22.65 |
$22,491 |
D/D |
993 |
6,023 |
|
- |
|
| Williams Patrick |
Director |
– • – |
2025-03-31 |
4 |
A |
$22.65 |
$13,114 |
D/D |
579 |
28,545 |
|
- |
|
| Kintiroglou Achilles B. |
SVP, General Counsel |
• – – |
2025-03-03 |
4 |
AS |
$27.75 |
$111,000 |
D/D |
(4,000) |
40,363 |
|
-14% |
|
| Kintiroglou Achilles B. |
SVP, General Counsel |
• – – |
2025-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
15,856 |
44,363 |
|
- |
|
| Kintiroglou Achilles B. |
SVP, General Counsel |
• – – |
2025-02-28 |
4 |
D |
$27.75 |
$131,285 |
D/D |
(4,731) |
28,507 |
|
- |
|
| Gramm Christopher |
Controller |
• – – |
2025-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
12,992 |
54,521 |
|
- |
|
| Gramm Christopher |
Controller |
• – – |
2025-02-28 |
4 |
D |
$27.75 |
$53,669 |
D/D |
(1,934) |
41,529 |
|
- |
|
| Kane Erin N |
Chief Executive Officer |
• • – |
2025-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
64,865 |
545,447 |
|
- |
|
| Kane Erin N |
Chief Executive Officer |
• • – |
2025-02-28 |
4 |
D |
$27.75 |
$616,411 |
D/D |
(22,213) |
480,582 |
|
- |
|
| Manjeshwar Siddharth |
SVP & Chief Financial Officer |
• – – |
2025-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
14,415 |
40,852 |
|
- |
|
399 Records found
|
|
Page 1 of 16 |
|
|
0.26 (1.23%) 
